Effect of avosentan (SPP-301) in porcine ciliary arteries

Current Eye Research

Volumn 36, Issue 2, 2011, Pages 118-124

  Konieczka, Katarzyna ^a   Meyer, Peter ^a   Schoetzau, Andreas ^a   Neutzner, Albert ^a   Mozaffarieh, Maneli ^a   Flammer, Josef ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Avosentan; Endothelin receptor antagonist; Glaucoma; Isolated ciliary arteries; Myography

Indexed keywords

AVOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ARTICLE; CILIARY ARTERY; CONCENTRATION RESPONSE; DRUG EFFECT; ENDOTHELIUM; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; CILIARY ARTERIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ISOMETRIC CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; PYRIDINES; PYRIMIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SWINE; VASOCONSTRICTION;

EID: 79551572410     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.529982     Document Type: Article

References (23)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Desai D, He S, Yorio T, et al. Hypoxia augments TNFalpha- mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem Biophys Res Commun. 2004;318:642-648.
3. Remuzzi G, Perico N, Benigni A. New therapeutics that antagonize endothelin: Promises and frustrations. Nat Rev Drug Discov. 2002;Dec 1:986-1001.
4. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: Is it a contributor to glaucoma pathophysiology? J Glaucoma. 2002;11:259-270.
5. Sugiyama T, Moriya S, Oku H, et al. Association of endothelin-1 with normal tension glaucoma: Clinical and fundamental studies. Surv Ophthalmol. 1995;39(Suppl 1):S49-S56.
6. Emre M, Orguel S, Haufschild T, ry s;/ Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005;89:60-63.
7. Tezel G, Kass MA, Kolker AE, et al. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6:83-89.
8. Polak K, Petternel V, Luksch A, et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci. 2001;42:2949-2956.
9. Polak K, Luksch A, Frank B, et al. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res. 2003;76:633-640.
10. Prasanna G, Krishnamoorthy R, Clark AF, et al. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002;43:2704-2713.
11. Taniguchi T, Shimazawa M, Sasaoka M, et al. Endothelin-1 impairs retrograde axonal transport and leads to axonal injury in rat optic nerve. Curr Neurovasc Res. 2006;3:81-88.
12. Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci. 1977;16:426-441.
13. Nyborg N, Prieto D, Benedito S, et al. Endothelin-1-induced contraction of bovine retinal small arteries is reversible and abolished by nitrendypine. Invest Ophthalmol Vis Sci. 1991;32:27-31.
14. Takei K, Sato T, Nonoyama T, et al. Analysis of vasocontractile responses to endothelin-1 in rabbit retinal vessels using an ETA receptor antagonist and an ETB receptor agonist. Life Sci. 1993;53:111-115.
15. Bursell S, Clermont A, Oren B, et al. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci. 1995;36:596-607.
16. Hein TW, Ren Y, Yuan Z, et al. Functional and molecular characterization of the endothelin system in retinal arterioles. Invest Ophthalmol Vis Sci. 2009;50:3329-3336.
17. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 1976;260:617-619.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289-300.
19. Smolander J, Vogt B, Maillard M, et al. Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects. Clin Pharmacol Ther. 2009;85:628-634.
20. Dieterle W, Mann J, Kutz K. Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects. J Clin Pharmacol. 2004;44:59-66.
21. Resch H, Karl K, Weigert G, et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2009;50:358-363.
22. Riezebos J, Watts IS, Vallance PJ. Endothelin receptors mediating functional responses in human small arteries and veins. Br J Pharmacol. 1994;111:609-615.
23. Deng LY, Li JS, Schiffrin EL. Endothelin receptor subtypes in resistance arteries from humans and rats. Cardiovasc Res. 1995;29:532-535.